Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015.
作者信息
Kassouf Wassim, Aprikian Armen, Black Peter, Kulkarni Girish, Izawa Jonathan, Eapen Libni, Fairey Adrian, So Alan, North Scott, Rendon Ricardo, Sridhar Srikala S, Alam Tarik, Brimo Fadi, Blais Normand, Booth Chris, Chin Joseph, Chung Peter, Drachenberg Darrel, Fradet Yves, Jewett Michael, Moore Ron, Morash Chris, Shayegan Bobby, Gotto Geoffrey, Fleshner Neil, Saad Fred, Siemens D Robert
机构信息
Department of urology, McGill University Health Centre, Montreal, QC, Canada;
Department of urology, University of British Columbia, Vancouver, BC, Canada;
出版信息
Can Urol Assoc J. 2016 Jan-Feb;10(1-2):E46-80. doi: 10.5489/cuaj.3583. Epub 2016 Feb 8.
Abstract
摘要
相似文献
1
Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015.加拿大膀胱癌医疗质量改善建议：一份由加拿大膀胱癌协会（BCC）、加拿大泌尿外科肿瘤学组（CUOG）和加拿大泌尿外科协会（CUA）于2015年12月审核并认可的共识文件。
Can Urol Assoc J. 2016 Jan-Feb;10(1-2):E46-80. doi: 10.5489/cuaj.3583. Epub 2016 Feb 8.
2
Continuing towards optimization of bladder cancer care in Canada: Summary of the third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting.加拿大膀胱癌护理持续优化：第三届加拿大膀胱癌-加拿大泌尿外科学会-加拿大泌尿肿瘤学组（BCC-CUA-CUOG）膀胱癌护理质量共识会议总结
Can Urol Assoc J. 2020 Mar;14(3):E115-E125. doi: 10.5489/cuaj.6378. Epub 2020 Feb 3.
3
Improving patient journey and quality of care: Summary from the second Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting.改善患者就医流程与医疗质量：加拿大膀胱癌-加拿大泌尿外科协会-加拿大泌尿肿瘤学组（BCC-CUA-CUOG）第二届膀胱癌医疗质量共识会议总结
Can Urol Assoc J. 2018 Jul;12(7):E281-E297. doi: 10.5489/cuaj.5246. Epub 2018 Mar 19.
4
Surgical wait times for patients with urological cancers: a survey of Canadian surgeons.泌尿系统癌症患者的手术等待时间：一项对加拿大外科医生的调查。
Can J Urol. 2006 Jun;13 Suppl 3:3-13.
5
UPDATE - 2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) castration-resistant prostate cancer (CRPC) guideline: What has changed since 2019?更新 - 2021年加拿大泌尿外科协会（CUA）-加拿大泌尿肿瘤学组（CUOG）去势抵抗性前列腺癌（CRPC）指南：自2019年以来有哪些变化？
Can Urol Assoc J. 2021 Feb;15(2):11-12. doi: 10.5489/cuaj.7160.
6
2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).2019年加拿大泌尿外科学会（CUA）-加拿大泌尿肿瘤学组（CUOG）指南：去势抵抗性前列腺癌（CRPC）的管理
Can Urol Assoc J. 2019 Oct;13(10):307-314. doi: 10.5489/cuaj.6136.
7
2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).2021年加拿大泌尿外科学会（CUA）-加拿大泌尿肿瘤学组（CUOG）指南：去势抵抗性前列腺癌（CRPC）的管理
Can Urol Assoc J. 2021 Feb;15(2):E81-E90. doi: 10.5489/cuaj.7074.
8
2022 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).2022年加拿大泌尿外科学会（CUA）-加拿大泌尿肿瘤学组（CUOG）指南：去势抵抗性前列腺癌（CRPC）的管理
Can Urol Assoc J. 2022 Nov;16(11):E506-E515. doi: 10.5489/cuaj.8161.
9
Consensus document: recommendations for optimal surgical wait times for patients with urological malignancies.共识文件：关于泌尿系统恶性肿瘤患者最佳手术等待时间的建议
Can J Urol. 2006 Jun;13 Suppl 3:62-4.
10
Choosing Wisely Canada cancer list: ten low-value or harmful practices that should be avoided in cancer care.明智选择加拿大癌症清单：癌症护理中应避免的十种低价值或有害做法。
J Oncol Pract. 2015 May;11(3):e296-303. doi: 10.1200/JOP.2015.004325.
引用本文的文献
1
Achieving health equity in bladder cancer care: Addressing disparities through collaborative research and evidence-based strategies.在膀胱癌护理中实现健康公平：通过合作研究和循证策略解决差异问题。
Bladder Cancer. 2024 Dec 23;10(4):264-269. doi: 10.1177/23523735241289237. eCollection 2024 Dec.
2
Follow-up strategies after trimodal treatment for muscle-invasive bladder cancer: a systematic review.肌层浸润性膀胱癌三联治疗后的随访策略：系统评价。
World J Urol. 2024 Sep 19;42(1):527. doi: 10.1007/s00345-024-05196-7.
3
Real-life benchmarking bladder cancer care: A population-based study.现实生活中膀胱癌护理的基准研究：一项基于人群的研究。
Can Urol Assoc J. 2023 Aug;17(8):268-273. doi: 10.5489/cuaj.8231.
4
CUA 2022 Annual Meeting Abstracts - Poster Session 11: EDI, COVID, Patient Relations Sunday, June 26, 2022 • 07:30-09:00.CUA 2022年会摘要 - 海报展示环节11：电子健康信息交换、新冠疫情与患者关系，2022年6月26日（周日）• 07:30 - 09:00
Can Urol Assoc J. 2022 Jun;16(6 Suppl 1):S105-S110. doi: 10.5489/cuaj.7933.
5
Building the Canadian Bladder Cancer Research Network (CBCRN): Progress during a pandemic.构建加拿大膀胱癌研究网络（CBCRN）：疫情期间的进展
Can Urol Assoc J. 2022 Jun;16(6):E307-E314. doi: 10.5489/cuaj.7810.
6
Cancer Prevalence and Risk Stratification in Adults Presenting With Hematuria: A Population-Based Cohort Study.血尿成年患者的癌症患病率及风险分层：一项基于人群的队列研究。
Mayo Clin Proc Innov Qual Outcomes. 2021 Jan 21;5(2):308-319. doi: 10.1016/j.mayocpiqo.2020.12.001. eCollection 2021 Apr.
7
Assessment of Diagnostic Yield of Cystoscopy and Computed Tomographic Urography for Urinary Tract Cancers in Patients Evaluated for Microhematuria: A Systematic Review and Meta-analysis.评估因镜下血尿就诊患者行膀胱镜检查和 CT 尿路造影对诊断泌尿系肿瘤的作用：系统评价和荟萃分析。
JAMA Netw Open. 2021 May 3;4(5):e218409. doi: 10.1001/jamanetworkopen.2021.8409.
8
The cost-effectiveness of schistosomiasis screening and treatment among recently resettled refugees to Canada: an economic evaluation.加拿大新定居难民血吸虫病筛查和治疗的成本效益：经济评价。
CMAJ Open. 2021 Feb 23;9(1):E125-E133. doi: 10.9778/cmajo.20190057. Print 2021 Jan-Mar.
9
Building a Canadian Translational Bladder Cancer Research Network.建立一个加拿大膀胱癌转化研究网络。
Can Urol Assoc J. 2020 Oct;14(10):E475-E481. doi: 10.5489/cuaj.6887.
10
Accuracy of ultrasound vs computed tomography scan for upper urinary tract malignancies and development of a risk-based diagnostic algorithm for haematuria in a UK tertiary centre.超声与计算机断层扫描对泌尿系统恶性肿瘤的诊断准确性及英国某三甲医院血尿患者基于风险的诊断算法的建立。
Int Urol Nephrol. 2021 Jan;53(1):49-57. doi: 10.1007/s11255-020-02615-7. Epub 2020 Aug 25.
本文引用的文献
1
A Single-centre Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL).一项关于开放性、机器人辅助及腹腔镜根治性膀胱切除术的单中心早期随机对照三臂试验（CORAL）
Eur Urol. 2016 Apr;69(4):613-621. doi: 10.1016/j.eururo.2015.07.038. Epub 2015 Aug 10.
2
Achieving Quality Assurance of Prostate Cancer Surgery During Reorganisation of Cancer Services.在癌症服务重组过程中实现前列腺癌手术的质量保证。
Eur Urol. 2015 Jul;68(1):22-9. doi: 10.1016/j.eururo.2015.02.028. Epub 2015 Mar 11.
3
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.根治性膀胱切除术治疗 pT3-pT4 或 N+M0 膀胱尿路上皮癌患者中即刻与延迟化疗的比较（EORTC 30994）：一项国际多中心、开放标签、随机 3 期临床试验。
Lancet Oncol. 2015 Jan;16(1):76-86. doi: 10.1016/S1470-2045(14)71160-X. Epub 2014 Dec 11.
4
Processes of care and the impact of surgical volumes on cancer-specific survival: a population-based study in bladder cancer.护理过程及手术量对癌症特异性生存的影响：一项基于人群的膀胱癌研究。
Urology. 2014 Nov;84(5):1049-57. doi: 10.1016/j.urology.2014.06.070. Epub 2014 Oct 24.
5
Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233.选择性膀胱保留联合治疗后肌层浸润性膀胱癌患者的长期预后：放射肿瘤学组8802、8903、9506、9706、9906和0233方案的汇总分析
J Clin Oncol. 2014 Dec 1;32(34):3801-9. doi: 10.1200/JCO.2014.57.5548. Epub 2014 Nov 3.
6
Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes.基于多学科团队（MDTs）重组癌症服务是否值得？对多学科团队的目标、组织及其对患者预后的影响进行的系统评价。
Health Policy. 2015 Apr;119(4):464-74. doi: 10.1016/j.healthpol.2014.09.006. Epub 2014 Sep 18.
7
Postoperative mortality and complications after radical cystectomy for bladder cancer in Quebec: A population-based analysis during the years 2000-2009.魁北克省膀胱癌根治性膀胱切除术后的死亡率和并发症：2000年至2009年基于人群的分析。
Can Urol Assoc J. 2014 Jul;8(7-8):259-67. doi: 10.5489/cuaj.1997.
8
Usefulness of transurethral biopsy for staging the prostatic urethra before radical cystectomy.经尿道活检在根治性膀胱切除术前行前列腺尿道分期中的应用价值。
J Urol. 2015 Jan;193(1):58-63. doi: 10.1016/j.juro.2014.07.114. Epub 2014 Aug 12.
9
The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review.淋巴结清扫范围对膀胱癌根治性切除术患者肿瘤学结局的影响：系统评价。
Eur Urol. 2014 Dec;66(6):1065-77. doi: 10.1016/j.eururo.2014.05.031. Epub 2014 Jul 26.
10
A randomized trial of robot-assisted laparoscopic radical cystectomy.机器人辅助腹腔镜根治性膀胱切除术的一项随机试验。
N Engl J Med. 2014 Jul 24;371(4):389-90. doi: 10.1056/NEJMc1405213.
Zotero 插件